Antisenescence Therapy Improves Function in a Human Model of Cardiac Fibrosis-on-a-Chip

Investigators previously developed a model of cardiac fibrosis via TGF-β treatment of engineered microtissues using heart-on-a-chip technology which incorporates human induced pluripotent stem cell-derived cardiomyocytes and cardiac fibroblasts.